Literature DB >> 17634714

Pneumocystis pneumonia in a patient with type 2 diabetes mellitus.

Ken Sanno1, Nobuyuki Hatanaka, Toru Yamagishi, Hirotaka Kamemura, Yusuke Hirano, Norio Kodaka, Atsuo Miura, Asako Kitahara, Tetsuro Sawata, Kimio Hosaka, Ichiro Nakazawa.   

Abstract

A 76-year-old man, who was in the hospital for the treatment of type 2 diabetes mellitus and was receiving gonadotropin-releasing hormone (GnRH) agonist treatment for prostate cancer, developed fever and hypoxemia. Imaging revealed diffuse interstitial shadows, and PCR of the bronchoalveolar lavage fluid was positive for Pneumocystis jirovecii. The patient's absolute CD4-positive lymphocyte count dropped to 145/microl, but the HIV antibody was negative. After trimethoprim-sulfamethoxazole (TMP/SXT) treatment, the absolute CD4 positive lymphocyte count returned to normal. This patient with type 2 diabetes mellitus developed Pneumocystis pneumonia and developed a transient decrease in CD4-positive lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634714     DOI: 10.2169/internalmedicine.46.0011

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  2 in total

1.  Differences in clinical Pneumocystis pneumonia in rheumatoid arthritis and other connective tissue diseases suggesting a rheumatoid-specific interstitial lung injury spectrum.

Authors:  Kota Shimada; Kyoko Yokosuka; Takahiro Nunokawa; Shoji Sugii
Journal:  Clin Rheumatol       Date:  2018-06-06       Impact factor: 2.980

2.  Molecular detection of Pneumocystis jirovecii using polymerase chain reaction in immunocompromised patients with pulmonary disorders in northeast of Iran.

Authors:  M Parian; A Fata; M J Najafzadeh; F Rezaeitalab
Journal:  Curr Med Mycol       Date:  2015-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.